Advertisement

Spotlight Series on Hepatitis C

U.S. News

Vertex Hepatitis C Drug Incivek Gets Black Box Warning Over Possible Fatal Skin Condition

December 20, 2012

The Food and Drug Administration (FDA) is requiring a black box warning on the Vertex Pharmaceuticals hepatitis C medication Incivek due to a potentially fatal skin rash. The FDA says that patients taking Incivek in combination with the medications ribavirin and interferon, which is taken by injection, should stop taking it immediately if they develop a rash that becomes worse or develops in tandem with other symptoms, such as fever, diarrhea, or mouth sores. The black box warning is the most serious form of safety warning available for medications.

Back to other news for December 2012

Adapted from:
Washington Post
12.19.2012; Associated Press




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.